Hepatitis in Taiwan
Taiwan hopes to eliminate chronic hepatitis and cirrhosis of the liver from the top ten fatal diseases list by 2017. In 2016, chronic hepatitis and cirrhosis of the liver were among the list of the top ten fatal diseases in 2016, both ranked at number 10.
The confidence comes from the expanded screening for hepatitis C and the use of oral medication to treat hepatitis C beginning in 2016, including Taiwanese universal medicare compensation for oral treatment of hepatitis C.
There are 2,300,000 chronic hepatitis B sufferers and 600,000 chronic hepatitis C sufferers. Liver fibrosis is the main cause of death of chronic hepatitis sufferers.
Taiwan also plans to lower the age for hepatitis B and hepatitis C screening from age 45 to age 40. A medical history tracking system is also being set up for high school students entering college and military conscription health checks to seek out carriers who have not been previously treated.
As to the number of cancer deaths in Taiwan, 47,760 cancer patients died in 2016, averaging out to 130 cancer deaths per day.